For shippers, carriers and consumers, was there ever a time when the near future seemed as uncertain as it does today?

The onset of the COVID-19 pandemic brought unprecedented disruption to drug development.

The coronavirus pandemic has laid bare the inadequacies of many supply chains when it comes to ensuring the safe, secure and rapid delivery of drugs and other critical supplies in a health crisis.

What makes a supply chain resilient? A discussion about the findings from a new study by the Council of Supply Chain Management Professionals and the MIT Center for Transportation and Logistics.

Suman Mahalanabis, director of product management for digital software and solutions with Tata Consultancy Services, describes the steps that factories will need to take in order to ensure the health and safety of workers during the pandemic and beyond.

What's the point at which manufacturers decide to shift production from China and return it to the U.S.? Gregory Burkart, managing director and leader of the Site Selection & Incentives Advisory Practice of financial consultancy Duff & Phelps, offers some insight into the calculation.

Automation was proceeding at a rapid pace in many factories and warehouses before the coronavirus pandemic hit. Now, however, concerns over worker health, the need for social distancing, and the relentless push for cost-cutting are accelerating the progress of robots for order fulfillment.